AI Analysis Can Improve Lung Cancer Detection on Chest Radiographs

– Study conducted by medical AI startup Lunit and Massachusetts General Hospital, published in JAMA Network Open

– When used as a second reader, the AI algorithm may help detect lung cancer

SEOUL, South Korea, Oct. 12, 2020 /PRNewswire/ — A recent study published in JAMA Network Open has shown that an AI algorithm trained to detect pulmonary nodules can improve lung cancer detection on chest radiographs.

The study was conducted by MGH and Lunit, a South Korean medical AI company. The joint research team analyzed 5,485 chest radiographs collected from participants in the National Lung Screening Trial (NLST) with Lunit INSIGHT CXR, an AI software for diagnosing chest x-rays.

According to this diagnostic study, the sensitivity and specificity of the AI algorithm for finding malignant pulmonary nodules were 94% and 83%, respectively. It even had a higher sensitivity compared to NLST radiologists, implementing its possibility to help detect lung cancer when used as a second reader.

“Low-dose CT is recommended for lung cancer screening because the detection of chest radiographs is challenging for radiologists due to its projectional nature of radiography,” explained Subba Digumarthy, the senior author of the study and an attending thoracic radiologist at MGH. “However, compared with chest radiography, CT is less accessible and more expensive, exposing patients to a higher dose of radiation. This study shows that AI can provide diagnostic value to more patients by supplementing the shortcomings and maintaining the advantages of x-ray diagnosis.”

“Through this first collaboration with the MGH research team, we are happy to validate the generalizability and accuracy of our AI approach based on NLST data,” said Brandon Suh, CEO of Lunit. “It is a meaningful study to show Lunit INSIGHT CXR can be utilized to diagnose cancer-related nodules and detect lung cancer in earlier stages.”

Lunit Insight CXR analyzes more than 3 million images in more than 80 countries, and has an accuracy of 97 to 99% in detecting 10 major chest diseases such as lung nodules and pneumothorax. It is CE marked and clinically available in Europe.

Media Contact
Yunyoung Noh, Communications Manager, Lunit
media@lunit.io

Support Independent Community Journalism

Dear Reader,

The Indian Sun exists for one reason: to tell stories that might otherwise go unheard.
We report on local councils, state politics, small businesses and cultural festivals. We focus on the Indian diaspora and the wider multicultural community with care, balance and accountability. We publish in print and online, send regular newsletters and produce video content. We also run media training programs to help community organisations share their own stories.

We operate independently.

Community journalism does not have the backing of large media corporations. Advertising revenue fluctuates. Platform algorithms change. Costs continue to rise. Yet the need for credible, grounded reporting in a multicultural Australia has never been greater.

When you support The Indian Sun, you support:

• Independent reporting on issues affecting migrant communities
• Coverage of local and state decisions that shape daily life
• A platform for small businesses and community groups
• Media training that builds skills within the community
• Journalism accountable to readers

We cannot cover everything, but we work to cover what matters.

If you value thoughtful reporting that reflects Australia’s diversity, we invite you to contribute. Every donation helps us maintain the quality and consistency of our work.

Please consider making a contribution today.

Thank you for your support.

The Indian Sun Team